Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Bruceantin is a quassinoid originally isolated from B. antidysenterica that has diverse biological activities.1,2,3 It inhibits protein synthesis in HeLa cells, reticulocytes, and reticulocyte lysates (IC50s = 30, 40, and 1,600 nM, respectively).1 Bruceantin is active against chloroquine-sensitive and -resistant strains of P. falciparum (IC50s = 8 and 13 nM, respectively).2 It induces apoptosis in HL-60 leukemia and RPMI-8226 multiple myeloma cells (IC50s = 12.2 and 12.8 nM, respectively).3 Bruceantin (5 mg/kg) induces tumor regression in an RPMI-8226 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol. Pharmacol. 12(1), 167-176 (1976).
2. Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis. Biochem. Pharmacol. 40(2), 297-301 (1990).
3. Antitumor activity of bruceantin: An old drug with new promise. J. Nat. Prod. 67(2), 269-272 (2004).